Cas:238764-30-2 methyl 4-amino-3,4-dihydro-2H-chromene-8-carboxylate manufacturer & supplier

We serve Chemical Name:methyl 4-amino-3,4-dihydro-2H-chromene-8-carboxylate CAS:238764-30-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 4-amino-3,4-dihydro-2H-chromene-8-carboxylate

Chemical Name:methyl 4-amino-3,4-dihydro-2H-chromene-8-carboxylate
CAS.NO:238764-30-2
Synonyms:4-Amino-chroman-8-carboxylic acid methyl ester 1HCl salt
Molecular Formula:C11H14ClNO3
Molecular Weight:243.68700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:61.55000
Exact Mass:243.06600
LogP:2.75780

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-Amino-chroman-8-carboxylic acid methyl ester 1HCl salt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Amino-chroman-8-carboxylic acid methyl ester 1HCl salt physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Amino-chroman-8-carboxylic acid methyl ester 1HCl salt Use and application,4-Amino-chroman-8-carboxylic acid methyl ester 1HCl salt technical grade,usp/ep/jp grade.


Related News: Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business. methyl 4-amino-3,4-dihydro-2H-chromene-8-carboxylate manufacturer Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development. methyl 4-amino-3,4-dihydro-2H-chromene-8-carboxylate supplier The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. methyl 4-amino-3,4-dihydro-2H-chromene-8-carboxylate vendor Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves. methyl 4-amino-3,4-dihydro-2H-chromene-8-carboxylate factory Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.